DIA 2018 Global Annual Meeting

The Life Sciences industry problem of bringing cost-effective medicines faster to the market requires significant disruption in the traditional approach of clinical development process. Sponsors need to establish innovative partnership models with their service providers while embracing Next-Gen clinical platforms which deliver intelligent, automated and agile clinical development capabilities on cloud.; TCS investments into such cloud based innovative clinical platforms enables sponsors to embrace them in either Software as a Service (SaaS) OR Business Process as a Service (BPaaS) models to disrupt traditional way of doing clinical research.